Cohance Lifesciences Limited has informed the Exchange regarding resignation of Mr Kundan Kumar Jha as Company Secretary & Compliance Officer of the Company w.e.f. close of business hours on February 04, 2026.
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Kundan Kumar Jha has resigned from his position as Company Secretary and Compliance Officer of Cohance Lifesciences Limited, effective from the close of business hours on February 4, 2026. The Company Secretary is a Key Managerial Personnel under the Companies Act and also serves as the Compliance Officer for exchange-related obligations. No reason for the resignation or details of a successor have been disclosed in this filing. This is a routine KMP-level exit, but the dual role means the company will need to fill both positions to maintain regulatory compliance.
Short-term impact is likely neutral as this is a mid-level KMP exit, though investors should watch for an announcement on a replacement to ensure compliance continuity. Prolonged vacancy in the Compliance Officer role could affect timely filings and disclosures.